Literature DB >> 26254482

Nucleotide carriers for anti-tumour actinomycin antibiotics.

N L Vekshin1, V I Kovalev2.   

Abstract

We have investigated a number of complexes of 7-aminoactinomycin D (7AAMD), with its potential carriers: caffeine, folic acid (FA), purine bases-guanine and adenine, pyrimidine base-thymine and with fragmented DNA to determine more stable and suitable complex. The process of binding of the fluorescent antibiotic with clusters of caffeine, guanine, adenine, thymine and with fragmented DNA was accompanied by a considerable long-wavelength shift in excitation spectrum. The energy of interaction between phenoxazine hetero-cycle of 7AAMD and chromophores of the carriers studied has been found. In the case of 7AAMD with guanine, adenine, thymine and caffeine, the energy is about of 7 kcal/mol, which is a little lower than in the case with DNA (7.7 kcal/mol). On the basis of emission spectra, in all examined compounds, with the exception DNA, the 7AAMD molecule emits photons from water phase, not from a cluster, since photo-excitation leads to desorption of the antibiotic from a cluster surface. We observed also the mutual fluorescence quenching of 7AAMD and FA in their complex. It may well be that this complex forms due to interaction of peptide-lactone rings of 7AAMD with system of FA. In the case of DNA, the complex with 7AAMD has very high stability that is determined not only by interaction between phenoxazine of 7AAMD and the DNA bases, but it is largely owing to the interaction between two peptide-lactone rings of 7AAMD and the DNA deoxyribose-phosphate chains.
© The Authors 2015. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  7-aminoactinomycin; actinomycin; caffeine; fluorescence spectroscopy; fragmented DNA

Mesh:

Substances:

Year:  2015        PMID: 26254482      PMCID: PMC4882642          DOI: 10.1093/jb/mvv075

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  18 in total

1.  The role of the loop in binding of an actinomycin D analog to hairpins formed by single-stranded DNA.

Authors:  R M Wadkins; C S Tung; P M Vallone; A S Benight
Journal:  Arch Biochem Biophys       Date:  2000-12-01       Impact factor: 4.013

2.  [Hairpin oligonucleotides as actinomycin carriers].

Authors:  N L Vekshin; I V Savintsev
Journal:  Biofizika       Date:  2009 Nov-Dec

3.  Hetero-association of caffeine and aromatic drugs and their competitive binding with a DNA oligomer.

Authors:  D B Davies; D A Veselkov; L N Djimant; A N Veselkov
Journal:  Eur Biophys J       Date:  2001-09       Impact factor: 1.733

4.  Extracting thermodynamic data from equilibrium melting curves for oligonucleotide order-disorder transitions.

Authors:  K J Breslauer
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Actinomycin D binds to metastable hairpins in single-stranded DNA.

Authors:  R M Wadkins; B Vladu; C S Tung
Journal:  Biochemistry       Date:  1998-08-25       Impact factor: 3.162

6.  Stopped-flow kinetic studies of actinomycin binding to DNAs.

Authors:  R Bittman; L Blau
Journal:  Biochemistry       Date:  1975-05-20       Impact factor: 3.162

7.  [Caffeine clusters as transmitters of actinomycin antibiotics to DNA in solutions].

Authors:  M A Bitekhtina; N L Vekshin
Journal:  Bioorg Khim       Date:  2008 Mar-Apr

8.  Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases.

Authors:  R L Rill; K H Hecker
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

9.  Binding of actinomycin D to single-stranded DNA of sequence motifs d(TGTCT(n)G) and d(TGT(n)GTCT).

Authors:  Fu-Ming Chen; Feng Sha; Ko-Hsin Chin; Shan-Ho Chou
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

10.  Kinetic evidence for redistribution of actinomycin molecules between potential DNA-binding sites.

Authors:  K R Fox; M J Waring
Journal:  Eur J Biochem       Date:  1984-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.